Emmanuel Macron summoned the director of Sanofi to tell him that a vaccine cannot be a market good. This controversy around Sanofi is also a challenge for the President of the Republic who places economic sovereignty at the heart of his plan to end the crisis. We are in complete contradiction.
Yes, you remember the words of Emmanuel Macron in Angers in a mask factory: rupture and takeover. We had to regain control to reduce our dependence. A few days ago, it was Bruno Le Maire who put on a layer, recalling that the recovery plan planned for the fall would encourage economic patriotism. But now, the case of Sanofi vaccines cruelly reminds French leaders of their mismatch between their good intentions and reality. Sanofi, which is more than 60% owned by foreign shareholders, is a multinational, in a strategic sector like health, where global competition is extremely strong. It benefits from both French research tax credit and American financial support. But the big difference between France and the United States is that when the Americans make a deal, there are conditions ... unlike the French. It is precisely there that the stick hurts and that it is practically impossible today to impose, in business, any national sovereignty. Currently, at the Élysée, we phosphorus ... We are still hesitant to set up fiscal and economic systems to reform the right to competition and favor French and European groups. But it is far from being won! It will take more than a rebuke and a moral lesson from the President of the Republic to the leaders of Sanofi to really change things. And for, as Emmanuel Macron said, regain control of our destiny and really break with the world before the coronavirus.